SHORTEX PRESS

Joseph Parnes will be speaking at the Reuters AdvicePoint Forum 2007 at The New York Athletic Club on Tuesday, November 6, 2007 1:15 PM

. Technomart Investment Advisors,publisher of Shortex is ranked as on of the top money managers in the Baltimore Business Journal for 2007 click here

Joseph Parnes on RIM Bloomberg News October 01 2007 click here

Joseph Parnes featured in The Baltimore Sun short on Under Armour Aug 12 2007 click to view the article.

Technomart Investment Advisors, publisher of Shortex ranked again in Wealth Manager's Top Wealth Managers 2007 click for more information

Joseph Parnes on Bloomberg Television's Opening Bell June 28th 2007click to view

Joseph Parnes on Radio Shack/Amazon Shorts Bloomberg News June 27th 2007 click here

Shortex in Barron's Market Watch June 12th 2007

Shortex in Barron's Market Watch May 07th 2007

Joseph Parnes on Bloomberg Television March 22nd 6:30 PM EST click to view

Bloomberg News `Short Sellers' Who Predicted Subprime Rout See More Declines March 21st 2007 click here

Joseph Parnes on Carl Icahn and Lear. Bloomberg News February 22nd 2007 click here

Joseph Parnes featured in Forbes recomendation on St.Jude Jan 31 2007 click to view the article.

Joseph Parnes on CNBC Power Lunch Jan 18th click to view

Joseph Parnes on Bloomberg Television's Market Pulse Dec 7th 2006click to view

Stern Investment Advisors recently brought on Technomart Investment Advisors as a sub-adviser for its high-net-worth client program Nov 20th 2006

Barron's feature article on Joseph Parnes "And Now a Word From The Dark Side" click to view

As of Sunday February 05, 8:11 AM EST

The markets last minute sell-off today due to the sell program is indicative of a needed digestion of the recent market plunge. Bearish tone rampant over 50%+. (Complete coverage)

Escalating woes for financial bell weather Citigroup /C/ is weighing on the market with continued rumors on the write-down/losses by other institutions. (Complete coverage)

New determinates on which sectors are hot and which are seemingly cold.(Complete coverage)

MYRIAD GENETICS /MYGN/ NSDAQ The biotechnology Co. focused on the marketing/development of novel therapeutic and molecular diagnostic products reported FY Q1 loss of $8 mil or 18c/shr on revenue increase of 44% to $48.3 mil (Complete coverage)

View our recent performance as it is matched against the market. (Find out why our performance is objective)

Shortex has the research you need to control the market

In either bull or bear markets, Shortex presents the best strategic approach.

Shortex provides you with the information and analysis you need to maintain both long and short positions and ensure a solid return on your investments by taking advantage of an up or down market Take a look for yourself with a tour, our performance, and a free issue

Shortex is well-known for its accurate forecasting & market-timing strategies, proven Buy/Sell advice, and insightful Long & Short recommendations. It provides you not with timid suggestions but with authoritative advisements that are well-researched, actionable, and confident.

This objectivity, honesty, and experience have led to the newsletter being respected by both media and private investors alike. (Find out why our performance is objective)

Find answers at the Shortex FAQ

Control the market today-Subscribe to Shortex-